Skip to main content
. 2024 Feb 21;10:e47130. doi: 10.2196/47130

Table 1.

Characteristics of the study population and overall changes in 4 outcome variables from January 2016 to December 2020 (N=45,582).

Characteristics Total (60 months; N=45,582) Pre-NIMSa (28 months; January 2016-April 2018; n=24,924) Post-NIMS Pre–COVID-19 (21 months; May 2018-January 2020; n=15,642) Post–COVID-19 (11 months; February 2020-December 2020; n=5016)
Sex, n (%)

Male 17,826 (39.1) 9591 (38.5) 6125 (39.2) 2110 (42.1)

Female 27,756 (60.9) 15,333 (61.5) 9517 (60.8) 2906 (57.9)
Age group (years), n (%)

20-39 5706 (12.5) 3236 (13) 1951 (12.5) 519 (10.3)

40-59 15,079 (33.1) 8401 (33.7) 5148 (32.9) 1530 (30.5)

60-74 15,752 (34.6) 8518 (34.2) 5397 (34.5) 1837 (36.6)

≥75 9045 (19.8) 4769 (19.1) 3146 (20.1) 1130 (22.5)
Insurance type, n (%)

NHIb 41,452 (90.9) 22,735 (91.2) 14,240 (91) 4477 (89.3)

MedAidc or PVId 4130 (9.1) 2189 (8.8) 1402 (9) 539 (10.7)
Morbidity, n (%)

Arthropathies 11,902 (26.1) 6533 (26.2) 4092 (26.2) 1277 (25.5)

Dorsopathies 21,234 (46.6) 11,588 (46.5) 7283 (46.6) 2363 (47.1)

Soft tissue disorders 11,908 (26.1) 6534 (26.2) 4086 (26.1) 1288 (25.7)

Otherse 538 (1.2) 269 (1.1) 181 (1.2) 88 (1.8)
Outcome variables, mean (SD)

Proportion of patients on high-dose opioid treatment N/Af 0.75 (0.22) 1.25 (0.27) 1.89 (0.30)

Proportion of patients receiving opioid prescriptions from multiple providers N/A 0.69 (0.27) 1.02 (0.27) 1.37 (0.37)

Overlap rate of opioid prescriptions per patient N/A 1.95 (0.42) 2.17 (0.20) 2.30 (0.30)

Naloxone use rate among opioid users N/A 0.57 (0.28) 0.51 (0.16) 0.45 (0.26)

aNIMS: Narcotics Information Management System.

bNHI: National Health Insurance.

cMedAid: Medical Aid.

dPVI: Patriots and Veterans Insurance.

eOther disorders of the musculoskeletal system and connective tissue.

fN/A: not applicable.